Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)

NCT00638248 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke

Interventions

DRUG: Desmoteplase
DRUG: Desmoteplase
DRUG: Placebo

Sponsor

PAION Deutschland GmbH